Home | UCB
4 days ago · At UCB, we believe that everyone deserves to live the best life that they can. That’s why – as a global biopharmaceutical leader - we’re focused on creating valuable solutions that make improvements to the lives of people living with neurological and autoimmune conditions now and into the future.
UCB in the U.S. | UCB
4 days ago · UCB is a global biopharma company focused on creating value for people living with severe diseases. Learn more about how UCB delivers value for patients through its patient assistance program, treatment tracker and more.
UCB (company) - Wikipedia
UCB (Union Chimique Belge) is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 [2] which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. [2]
Careers at UCB | UCB jobs
Let's push the boundaries together and make the most of your talents. Find available jobs in fields like Finance, Medical & Clinical, Sales & Marketing and more.
UCB Receives U.S. FDA Approval for BIMZELX® (bimekizumab …
4 days ago · UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living ...
UCB Receives U.S. FDA Approval for BIMZELX ... - Morningstar
4 days ago · UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living ...
Our Company | UCB
At UCB, we are consistently delivering on our commitment to improve the lives of people living with severe neurological and immunological conditions. And thanks to our focused, innovative and trusted solutions, our business is strong, with total revenue reaching € 5.3 billion in 2023.
- Some results have been removed